The "ENT Surgical Devices And Equipment Global Market Report 2020" report has been added to ResearchAndMarkets.com's offering.
The global ENT surgical devices and equipment market was valued at about $1.3 billion in 2018 and is expected to grow to $1.48 billion at a CAGR of 3.3% through 2022.
The ENT surgical devices and equipment market consists of sales of ENT (ear-nose-throat) surgical devices. ENT surgical devices include balloon sinus dilation devices, powered surgical instruments, ENT supplies, radiofrequency devices, ear tubes and handheld instruments are used to perform surgical procedures such as tonsillectomy, tracheostomy, implantations, septorhinoplasty, turbinate reduction, mastoidectomy, stapedectomy and reconstruction surgeries. Based on the mode of operation, this market is segmented into hand-held devices, portable devices and fixed devices.
North America was the largest region in the ENT surgical devices and equipment market in 2018. This region is expected to remain the largest during the next five years. The ENT surgical devices and equipment market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.
Increasing demand and adoption of minimally invasive ENT surgeries will drive the ENT surgical devices and equipment market in the future. For example, minimally invasive ENT surgeries offers patients with many benefits such as smaller incisions, faster recovery times, reduced pain, and scarring. In majority of the cases physicians enjoy higher accuracy rate compared to traditional open surgery. These supreme benefits of minimally invasive ENT surgeries will drive the market.
Lack of proper reimbursement policies for ENT surgical procedures, especially in developing and developed countries, is one of the major factors that could hinder the growth of the ENT surgical devices and equipment market. ENT surgical procedures are complex, involves greater devices and thus are relatively expensive. The lack of proper reimbursement policies may inhibit the growth of the ENT surgical devices and equipment market.
ENT procedures involving minimally invasive ENT tools are an alternative to major surgeries. It involves less tissue damage, reduced scarring and faster recovery thereby leading to greater adoption and would see an increase in the market potential. Robot assisted minimally invasive ENT procedures have transformed the treatment landscape of cancer associated with ear, nose, and throat. For treating benign and malignant conditions of the oropharynx and larynx, Transoral robotic surgery (TORS) is now being widely adopted.
The ENT surgical devices and equipment industry has lately witnessed a rise in number of FDA clearances which would positively impact the market growth. A pre-market approval by FDA through FDA 510(K) is required for all the medical devices including ENT surgical devices. As announced by FDA in November 2018, the FDA 510(K) is expected to see number of updates in order to regulate safety, technology, and capabilities in the medical devices space. In 2017, the European Union's Medical Device Regulation (MDR) presented a few changes that would come into force by 2020. The changes made to the regulation were in terms of recertification of legacy devices, as well as changes in the definition of regulated devices, safety measures, and risk management.
In February 2018, Stryker Corporation, a medical technology company acquired Entellus Medical, Inc. for $664 million. With this acquisition, it is expected to consolidate Stryker's position in the ENT surgical devices market with a firm grip on minimally invasive surgeries. Entellus Medical, Inc., a US-based company involved in the manufacturing of ENT surgical devices for minimally invasive treatment of patients suffering from various ENT diseases.
Major players in the market are Carl Zeiss Meditec AG, Stryker, Shanghai Fosun Pharmaceuticals Ltd., KLS Martin LP, Acclarent, Inc.
Other Companies Mentioned
- Smith & Nephew
- Boston Scientific
- Collin SAS
- Cochlear Limited
- Hoya Corporation
- William Demant
- Sonova Holding
- Spiggle &Theis
- Zhejiang Tiansong Medical Instrument Co. Ltd.
- Boston Scientific
- ZEISS International
- Reda Instrumente GmbH
- Conmed Corporation
- Intersect ENT
- Happersberger Otopront GmbH
- Welch Allyn
For more information about this report visit https://www.researchandmarkets.com/r/fqxytg
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900